Both in Pharmaceuticals
CAMP4 Therapeutics vs Nature's Sunshine Products
Over the past year CAMP returned −2.8% and NATR returned −12.3%; their daily moves had a correlation of 0.01.
CAMP −2.8% NATR −12.3%Growth of $1, one year, split-adjusted
| Metric | CAMP | NATR |
|---|---|---|
| Price | $3.83 | $12.07 |
| Market cap | $240.3M | $212.4M |
| Today | +1.46% | +0.42% |
| 1 month | −4.5% | −2.7% |
| 6 months | −3.8% | −53.4% |
| Year to date | −37.5% | −44.1% |
| 1 year | −7.9% | −10.5% |
| Revenue growth (YoY) | +18.8% | +1.9% |
| Gross margin | 100.0% | 73.7% |
| Net margin | −1884.8% | 3.0% |
| P/E (TTM) | — | 11.7× |
| Price / sales | 57.0× | 0.4× |
| Net cash | $86.4M | $82.5M |
| Dividend yield | — | — |
| Volatility (60d) | 83.9% | 20.4% |
| Short % of float | 8.2% | 6.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).